More recently, we have shown that genetic deletion of MPC2 in HSC cells reduces their proliferation and activation in vitro and protects mice from HSC activation in a mouse model of NASH (unpublished observation). This evidence concerns the gene MPC2 and metabolic dysfunction-associated steatohepatitis.